Libeo 40 mg Chewable Tablets for Dogs

Land: Storbritannien

Språk: engelska

Källa: VMD (Veterinary Medicines Directorate)

Aktiva substanser:

Furosemide

Tillgänglig från:

Ceva Animal Health Ltd

ATC-kod:

QC03CA01

INN (International namn):

Furosemide

Läkemedelsform:

Chewable tablet

Receptbelagda typ:

POM-V - Prescription Only Medicine – Veterinarian

Terapeutisk grupp:

Dogs

Terapiområde:

Cardio Vascular diuretic

Bemyndigande status:

Authorized

Tillstånd datum:

2014-03-04

Produktens egenskaper

Revised: October 2022
AN: 01670/2022
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
LIBEO 40 MG CHEWABLE TABLETS FOR DOGS
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One tablet of 1320 mg contains :
ACTIVE SUBSTANCE:
Furosemide .........................................................40
mg
EXCIPIENT(S):
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Chewable tablet
Clover shape beige tablet. The tablets can be divided into equal
quarters
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of ascites and oedema, particularly associated with cardiac
insufficiency
4.3
CONTRAINDICATIONS
Do not use in dogs suffering from hypovolaemia, hypotension or
dehydration.
Do not use in cases of renal failure with anuria.
Do not use in cases of electrolyte deficiency.
Do not use in cases of hypersensitivity to furosemide, sulfonamides or
any of the
excipients.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Therapeutic efficacy may be impaired by increased intake of drinking
water. Where
the animal’s condition permits, water intake should be restricted to
physiologically
normal levels during treatment.
Revised: October 2022
AN: 01670/2022
Page 2 of 6
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
As the tablets are flavoured, they should be stored in a safe place
out of the reach of
animals.
Furosemide should be used with caution in case of pre-existing
electrolyte and/or
water imbalance, impaired hepatic function (may precipitate hepatic
coma) and
diabetes
mellitus.
In
case
of
prolonged
treatment,
hydration
status
and
serum
electrolytes should be monitored frequently.
1-2 days before and after commencement of treatment with diuretics and
ACE
inhibitors renal function and hydration status should be monitored.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY
MEDICINAL PRODUCT TO ANIMALS
People with known hypersensitivity to furosemide should avoid conta